University of Pennsylvania, 3440 Market Street, Suite 370, Philadelphia, PA 19104, USA; Philadelphia VAMC, University and Baltimore Avenues, Philadelphia, PA 19104, USA.
University of Pennsylvania, 3440 Market Street, Suite 370, Philadelphia, PA 19104, USA.
Addict Behav. 2014 Mar;39(3):660-8. doi: 10.1016/j.addbeh.2013.11.019. Epub 2013 Dec 1.
The goal of this study was to determine which cocaine dependent patients engaged in an intensive outpatient program (IOP) were most likely to benefit from extended continuing care (24 months). Participants (N=321) were randomized to: IOP treatment as usual (TAU), TAU plus Telephone Monitoring and Counseling (TMC), or TAU plus TMC plus incentives for session attendance (TMC+). Potential moderators examined were gender, stay in a controlled environment prior to IOP, number of prior drug treatments, and seven measures of progress toward IOP goals. Outcomes were: (1) abstinence from all drugs and heavy alcohol use, and (2) cocaine urine toxicology. Follow-ups were conducted at 3, 6, 9, 12, 18, and 24 months post-baseline. Results indicated that there were significant effects favoring TMC+ over TAU on the cocaine urine toxicology outcome for participants in a controlled environment prior to IOP and for those with no days of depression early in IOP. Trends were obtained favoring TMC over TAU for those in a controlled environment (cocaine urine toxicology outcome) or with high family/social problem severity (abstinence composite outcome), and TMC+ over TAU for those with high family/social problem severity or high self-efficacy (cocaine urine toxicology outcome). None of the other potential moderator effects examined reached the level of a trend. These results generally do not suggest that patients with greater problem severity or poorer performance early in treatment on the measures considered in this report will benefit to a greater degree from extended continuing care.
本研究旨在确定参加强化门诊项目(IOP)的可卡因依赖患者中,哪些患者最有可能从延长的延续护理(24 个月)中受益。参与者(N=321)被随机分配到:IOP 常规治疗(TAU)、TAU 加电话监测和咨询(TMC)或 TAU 加 TMC 加出席会议奖励(TMC+)。检查的潜在调节因素包括性别、IOP 前在受控环境中的停留时间、先前药物治疗的次数以及七个IOP 目标进展的衡量标准。结果是:(1)所有毒品和大量饮酒的戒除,以及(2)可卡因尿液毒理学。在基线后 3、6、9、12、18 和 24 个月进行随访。结果表明,对于在 IOP 前处于受控环境中的参与者和在 IOP 早期没有抑郁天数的参与者,TMC+ 与 TAU 相比,在可卡因尿液毒理学结果方面有显著的优势。对于处于受控环境(可卡因尿液毒理学结果)或家庭/社会问题严重程度高(戒除综合结果)的参与者,TMC 比 TAU 更有优势,而对于家庭/社会问题严重程度或自我效能高(可卡因尿液毒理学结果)的参与者,TMC+ 比 TAU 更有优势。未发现其他潜在调节因素的影响达到趋势水平。这些结果一般不表明在本报告中考虑的措施中,早期治疗时问题严重程度较高或表现较差的患者将从延长的延续护理中受益更大。